Prevalencia de obesidad e hiperglucemia en mujeres con diagnóstico de síndrome de ovario poliquístico atendidas en el Hospital IESS-Ceibos durante el año 2022.

Abstract

This research work addresses the prevalence of obesity and hyperglycemia in women diagnosed with polycystic ovary syndrome treated at the IESS-Ceibos Hospital during the year 2022. Polycystic ovary syndrome has been defined as a common endocrinological pathology in women of childbearing age, whose main characteristic is ovulatory dysfunction caused by hyperandrogenism, which manifests itself through the presence of hirsutism, acne, menstrual cycle disorders and the presence of ovarian cysts. In addition, polycystic ovary syndrome is associated with metabolic disorders, so this disease has a negative impact on the quality of life of women who suffer from it. The objective of the research is to determine the prevalence of obesity and hyperglycemia in women diagnosed with polycystic ovary syndrome. A sample of 58 patients was taken, where it was identified that the predominant age range is 26 to 30 years, of which 16 presented normal weight, 14 were overweight, 23 had type I obesity and 4 had type II obesity. In addition, when relating the BMI with the diagnosis of basal glucose, it was observed that patients with overweight and type I obesity presented hyperglycemia, which are represented in the same percentage with 33.30%. This was followed by patients with type II obesity, with 22.20%. It is concluded that statistically polycystic ovary syndrome is directly related to weight gain and hyperglycemia.